Sanofi/Regeneron's IL-4 and IL-13 inhibitor Dupixent (dupilumab) was approved to treat CRSwNP in 2019 ... and 25% to 30% of them develop nasal polyps as a result. Sanofi and Regeneron have ...

When caused by allergies, post-nasal drip can be mitigated by avoiding allergy triggers. Over-the-counter medications may also help treat post-nasal drip. See a healthcare provider if you have a ...

Aclaris Therapeutics, Inc.’s ACRS share price has surged by 6.72%, which has investors questioning if this is right time to sell.

Roshni Naik, MD, allergist at Mount Sinai Health System, discusses the history of present illness for a case of severe asthma with nasal polyps: "Patient is a 45 year-old male with a past medical ...

New Phase II data demonstrate amlitelimab’s efficacy in heterogeneous inflammatory asthma, as lunsekimig and itepekimab ...

Chile will use an anti-terrorism law to pursue those responsible for an arson attack on a Chinese-owned power project in the south, one of the most destructive attacks in decades in a region ...

4, 2025 — The probability of revision sinus surgery including the removal of nasal polyps is higher if the patient has asthma or is on antibiotics at the time ... Feb. 3, 2025 — A multi ...

At close: April 23 at 4:00:01 PM EDT ...

An alternative, nasal spray, formulation has been developed that demonstrates good efficacy, high tolerability and a very fast onset of action. This study assessed the pharmacokinetics and ...